News and Announcements
Alcidion Appoint Resapp Health Co-Founder Brian Leedman
- Published July 28, 2016 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
28th July 2016, ASX Announcement
Alcidion Group Limited (ASX: ALC), a global leader in Clinical Informatics, today announced the appointment of Mr. Brian Leedman to the bord of the Company. This move comes at a pivotal time for Alcidion as the Company looks to expand market share of their award-winning Miya Platform product internationally.
Mr. Leedman is the co-founder of Resapp Health (ASX: RAP) where he currently serves in the role of the Executive Director and Vice President, Corporate Affairs. Mr Leedman is a marketing and investor relations professional with over 10 years’ experience in the biotechnology / healthcare industry. Prior to Resapp Helath, Mr. Leedman co-founded Enigma Therapeutics which listed on the ASX in 2013 as OncoSil Medical Limited.
Mr. Leedman previously served for 10 years as Vice President, Investor Relations for pSivida Corp. which is listed on the ASX and NASDAQ.
To view the full announcement, please click on the button below.